📰 Dosing With News
Page 2 - Dosing With News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Dosing With. Real-time updates on events, politics, business and more.
May 23, 2022
Data from Up to Six Months of Treatment with Aficamten Show Significant and Sustained Reductions in LVOT Gradients with Improvements in Functional Class,...
May 4, 2022
Initial Data from REDWOOD-HCM OLE, the Open Label Extension Study of Aficamten, to be Presented at Heart Failure 2022 on May 23, 2022 Continued Launch...
April 2, 2022
Aficamten Reduced LVOT Gradients and Improved NYHA Class and NT-proBNP in Patients with Obstructive Hypertrophic Cardiomyopathy Treated with Disopyramide...
April 2, 2022
SOUTH SAN FRANCISCO, Calif., April 02, 2022 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated CYTK today announced that the full results from Cohort 3 of